Punctal occlusion in the management of chronic Stevens-Johnson syndrome

被引:48
作者
Kaido, M
Goto, E
Dogru, M
Tsubota, K
机构
[1] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba, Japan
[2] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan
关键词
D O I
10.1016/j.ophtha.2003.09.034
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the effect of lacrimal punctal occlusion in the management of the ocular surface disease in chronic Stevens-Johnson syndrome. Design: Retrospective noncomparative case series. Participants: Thirty-one eyes of 18 patients with chronic Stevens-Johnson syndrome seen at the Department of Ophthalmology of the Tokyo Dental College were studied. Intervention: Patients' lacrimal puncta were occluded by cauterization or with punctal plugs. Main Outcome Measures: The effect of lacrimal punctal occlusion was evaluated by changes in subjective symptoms, best-corrected visual acuity (VA), Schimer test, tear clearance test, and ocular surface double vital staining before and after punctal occlusion. Results: After lacrimal punctal occlusion, symptomatic improvement was observed in 19 eyes (61.3%). The mean logarithmic VA showed significant improvement from -0.64 +/- 0.87 to -0.52 +/- 0.86 (P<0.05). The Schirmer I test results before punctal occlusion yielded a mean score of 7.4 +/- 8.7 mm, which changed to 10.2 +/- 8.3 mm after punctal occlusion. The mean preocclusion and postocclusion tear clearance values were 7.5 +/- 6.6 times and 4.9 +/- 4.8 times, respectively. The Rose Bengal staining score decreased from 4.7 +/- 2.8 to 2.7 +/-2.2 points (P<0.05), and the fluorescein staining score decreased from 5.0 +/- 2.3 to 2.2 +/- 2.5 points (P<0.05), respectively. Conclusions: Concurrent improvements in subjective symptoms, vital staining scores, and VA point to the favorable effects of lacrimal punctal occlusion for the ocular surface health in chronic Stevens-Johnson syndrome. Ophthalmology 2004;111:895-900 (C) 2004 by the American Academy of Ophthalmology.
引用
收藏
页码:895 / 900
页数:6
相关论文
共 24 条
[1]  
Araujo O E, 1984, J Emerg Med, V2, P129, DOI 10.1016/0736-4679(84)90332-9
[2]  
DOHLMAN C, 1994, LACRIMAL GLAND TEAR, P350
[3]   EFFECTS OF AFGF AND BFGF ON WOUND-HEALING IN RABBIT CORNEAS [J].
FREDJREYGROBELLET, D ;
PLOUET, J ;
DELAYRE, T ;
BAUDOUIN, C ;
BOURRET, F ;
LAPALUS, P .
CURRENT EYE RESEARCH, 1987, 6 (10) :1205-1209
[4]   Impaired functional visual acuity of dry eye patients [J].
Goto, E ;
Yagi, Y ;
Matsumoto, Y ;
Tsubota, K .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (02) :181-186
[5]   Epithelial stem-cell transplantation for severe ocular-surface disease [J].
Holland, EJ ;
Schwartz, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) :1752-1753
[6]   The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium [J].
Jackson, RS ;
Van Dyken, SJ ;
McCartney, MD ;
Ubels, JL .
CORNEA, 2001, 20 (05) :516-521
[7]   Effect of retinol palmitate as a treatment for dry eye: A cytological evaluation [J].
Kobayashi, TK ;
Tsubota, K ;
Takamura, E ;
Sawa, M ;
Ohashi, Y ;
Usui, M .
OPHTHALMOLOGICA, 1997, 211 (06) :358-361
[8]   Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome [J].
Marsh, P ;
Pflugfelder, SC .
OPHTHALMOLOGY, 1999, 106 (04) :811-816
[9]  
Nishida T, 1996, J CELL PHYSIOL, V169, P159, DOI 10.1002/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.3.CO
[10]  
2-6